Has Ozempic killed body inclusivity?
from Ladies, We Need To Talk Hosted by Australian Broadcasting Corporation
Ozempic has entered the group chat. Since GLP-1 agonist drugs burst onto the scene, they've been hailed as a weight-loss game changer, but they've also raised uncomfortable questions about what bodies are acceptable, or not. For years, the body inclusivity movement pushed back against the idea that only thin bodies can be 'healthy' but Ozempic & co are drowning out this message. So, what do these drugs mean for fat liberation? And how can we shift our collective thinking around weight and morality? Yumi Stynes chats to a panel of amazing women about the impact of this new generation of weight-loss drugs and how we can all find ways to be kinder to our bodies. Featured in this conversation: Dr Emma Beckett, nutritionist Evie Gardiner, size inclusivity advocate Nat Atkinson, mum taking Wegovy What to listen to next: The Ozempic eraI'm fat, don't hate me—Aubrey GordonFat talk You can binge more episodes of Ladies, We Need to Talk on the ABC listen app (in Australia) or wherever you get your podcasts. What to read next: Why Kate chose to 'stay flat' after breast cancer surgeryHow Turia Pitt's body image changed in motherhoodThe women staying single by choice in a world of relentless dating pressureSugar babies give rich, older men the 'full girlfriend experience' at a price This episode will address questions like, what does it feel like to be a fat woman today? Is there increasing pressure to go on weight loss drug Ozempic? How has the rise in Ozempic impacted fat women? What is it like to loose a lot of weight? How does society treat you differently after weight loss?
Embed this episode
No transcript yet.